Authors: Vikramaditya G. Yadav
Published: 2019-07-17
DOI: 10.1126/scitranslmed.aay3576
Source: Full article
A probiotic engineered to express a fusion of two tumor-inhibiting proteins shows targeted anticancer activity in mice.